Shareholders’ Equity - Schedule of Stock Authorized and Issued (Details) - $ / shares	3 Months Ended					9 Months Ended
	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2025	Dec. 31, 2024
Common Shares
Option exercised and converted under the Employee Stock Option Plan (in shares)	27,149	93,347
Issuance of Restricted Stock Awards under the Equity Incentive Plan (in shares)		191,526	191,526
Total Number of Ordinary Shares
Authorized, beginning balance (in shares)	600,000,000		600,000,000			600,000,000
Shares issued, beginning balance (in shares)	64,203,573		63,918,700			63,918,700
Authorized, ending balance (in shares)	600,000,000	600,000,000				600,000,000
Shares issued, ending balance (in shares)	64,230,722	64,203,573				64,230,722
Common Class A
Common Shares
Authorized, beginning balance (in shares)			500,000,000			500,000,000
Issued, beginning balance (in shares)			63,077,431			63,077,431
Authorized, ending balance (in shares)	500,000,000					500,000,000
Issued, ending balance (in shares)	63,704,544					63,704,544
Total Number of Ordinary Shares
Common stock, par value (CHF/USD per share)	$ 0.0001					$ 0.0001	$ 0.0001
Common Class C
Common Shares
Authorized, beginning balance (in shares)			100,000,000			100,000,000
Issued, beginning balance (in shares)			841,269			841,269
Authorized, ending balance (in shares)	100,000,000					100,000,000
Issued, ending balance (in shares)	526,178					526,178
Total Number of Ordinary Shares
Common stock, par value (CHF/USD per share)	$ 0.0001					$ 0.0001	$ 0.0001
Common Stock \| Common Class A
Common Shares
Authorized, beginning balance (in shares)	500,000,000		500,000,000			500,000,000
Issued, beginning balance (in shares)	63,474,253		63,077,431			63,077,431
Conversion of Class C Ordinary Shares into Class A Ordinary Shares (in shares)	203,142		111,949	153,998	1,493,356
Option exercised and converted under the Employee Stock Option Plan (in shares)	27,149	93,347	93,347	17,390
Issuance of Restricted Stock Awards under the Equity Incentive Plan (in shares)		191,526
Authorized, ending balance (in shares)	500,000,000	500,000,000				500,000,000
Issued, ending balance (in shares)	63,704,544	63,474,253				63,704,544
Total Number of Ordinary Shares
Common stock, par value (CHF/USD per share)	$ 0.0001					$ 0.0001
Common Stock \| Common Class A \| Conversion Of Class C into Class A
Common Shares
Conversion of Class C Ordinary Shares into Class A Ordinary Shares (in shares)	203,142	111,949
Common Stock \| Common Class C
Common Shares
Authorized, beginning balance (in shares)	100,000,000		100,000,000			100,000,000
Issued, beginning balance (in shares)	729,320		841,269			841,269
Conversion of Class C Ordinary Shares into Class A Ordinary Shares (in shares)	(203,142)		(111,949)	(153,998)	(1,493,356)
Authorized, ending balance (in shares)	100,000,000	100,000,000				100,000,000
Issued, ending balance (in shares)	526,178	729,320				526,178
Total Number of Ordinary Shares
Common stock, par value (CHF/USD per share)	$ 0.0001					$ 0.0001
Common Stock \| Common Class C \| Conversion Of Class C into Class A
Common Shares
Conversion of Class C Ordinary Shares into Class A Ordinary Shares (in shares)	(203,142)	(111,949)

MoonLake Immunotherapeutics 10-Q